Innocoll (INNL) Sank To A New Low After Receipt Of FDA Refusal To File Letter

Innocoll (INNL) announced Friday morning that it has received a Refusal to File letter from the FDA for XARACOLL, for the treatment of postsurgical pain.

from RTT - Before the Bell http://ift.tt/2hMMilZ
via IFTTT